首页> 外文会议>Asian Symposium on Biomedical Materials >In Vitro and In Vivo Biocompatibility of Nano-hydroxyapatite/Collagen Composites
【24h】

In Vitro and In Vivo Biocompatibility of Nano-hydroxyapatite/Collagen Composites

机译:体外和体内生物相容性纳米羟基磷灰石/胶原复合材料

获取原文

摘要

A nano-grade hydroxyapatite/collagen composite was prepared by an in situ synthesis technique from calcium nitrate, diammoniun hydrogen phosphate, and a cowhide collagen sol at low temperature. XRD and TEM analyses of the composite indicated that crystals formed in the collagen fibril matrix were nanohydroxyapatite with low crystallinity. Biocompatibility of the composite was evaluated by in vitro cytotoxicity test and in vivo genotoxicity and sensitization test. No mutagenic activity of the composite was observed in mouse micronucleus tests. No evidence of dermal sensitization of the composite was found in guinea pig maximization tests. The results from a filter diffusion test indicated that the composite did not induce a cytotoxic behavior. All these results suggest that the composite has excellent biocompatibility.
机译:通过在低温下由硝酸钙,Diatmoniun磷酸盐和牛胶原溶胶的原位合成技术制备纳米级羟基磷灰石/胶原复合物。复合材料的XRD和TEM分析表明,在胶原纤维基质中形成的晶体是具有低结晶度的纳米羟基磷灰石。通过体外细胞毒性测试和体内遗传毒性和敏化试验评估复合材料的生物相容性。在小鼠微核试验中未观察到复合材料的致突变性。在豚鼠最大化试验中没有发现复合材料真皮敏化的证据。来自过滤器扩散试验的结果表明复合物没有诱导细胞毒性行为。所有这些结果表明,复合材料具有优异的生物相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号